ATM is usually rearranged in T-cell prolymphocytic leukaemia

被引:72
作者
Yuille, MAR [1 ]
Coignet, LJA
Abraham, SM
Yaqub, F
Luo, L
Matutes, E
Brito-Babapulle, V
Vorechovsky, I
Dyer, MJS
Catovsky, D
机构
[1] Royal Marsden Hosp, NHS Trust, Inst Canc Res, Acad Dept Haematol & Cytogenet, London SW3, England
[2] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
关键词
T-prolymphocytic leukaemia; ATM; tumour suppressor; fluorescent in situ hybridization; single-strand conformation polymorphism; mutations;
D O I
10.1038/sj.onc.1201603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-prolymphocytic leukaemia (T-PLL) is a rare, sporadic leukaemia similar to a mature T-cell leukaemia seen in some patients with Ataxia Telangiectasia (A-T), a recessive multisystem disorder caused by mutations of the ATM gene at chromosome 11q23., ATM sequence mutations have been reported in 46% of T-PLL cases, but some cases also have karyotypic abnormalities at 11q, including 11q23., This led us to investigate the structure of the A TM locus in a panel of eight cases, two of which had 11q23 abnormalities, As expected, nucleotide changes were detected in some samples, Two remission samples were wild type, To test for structural lesions, DNA fibres were hybridized with a contig of four labelled cosmids spanning the A TM locus, In all samples there were structural lesions and in four samples both alleles were affected, This provides strong evidence for our suggestion that ATM acts as a tumour suppressor during T-PLL tumorigenesis. Some additional role for ATM during T-PLL tumorigenesis is possible since nucleotide changes were present in addition to structural lesions disrupting both alleles. The mechanism of inactivation appeared to be unusual because multiple structural Lesions on one allele were often observed,.
引用
收藏
页码:789 / 796
页数:8
相关论文
共 27 条
  • [1] Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
    Athma, P
    Rappaport, R
    Swift, M
    [J]. CANCER GENETICS AND CYTOGENETICS, 1996, 92 (02) : 130 - 134
  • [2] ISOLATION AND REGIONAL ASSIGNMENT OF HUMAN-CHROMOSOME 12P CDNAS
    BAENS, M
    AERSSENS, J
    VANZAND, K
    VANDENBERGHE, H
    MARYNEN, P
    [J]. GENOMICS, 1995, 29 (01) : 44 - 52
  • [3] BARTLETT RJ, 1989, LANCET, V1, P496
  • [4] ''AT risk'' for breast cancer
    Bebb, G
    Glickman, B
    Gelmon, K
    Gatti, R
    [J]. LANCET, 1997, 349 (9068) : 1784 - 1785
  • [5] INVERSIONS AND TANDEM TRANSLOCATIONS INVOLVING CHROMOSOME 14Q11 AND 14Q32 IN T-PROLYMPHOCYTIC LEUKEMIA AND T-CELL LEUKEMIAS IN PATIENTS WITH ATAXIA TELANGIECTASIA
    BRITOBABAPULLE, V
    CATOVSKY, D
    [J]. CANCER GENETICS AND CYTOGENETICS, 1991, 55 (01) : 1 - 9
  • [6] BRITOBABAPULLE V, 1987, BLOOD, V70, P926
  • [7] Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization
    Coignet, LJA
    Schuuring, E
    Kibbelaar, RE
    Raap, TK
    Kleiverda, KK
    Bertheas, MF
    Wiegant, J
    Beverstock, G
    Kluin, PM
    [J]. BLOOD, 1996, 87 (04) : 1512 - 1519
  • [8] UNUSUAL DELETIONS WITHIN THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS IN ACUTE LEUKEMIAS
    DYER, MJS
    HEWARD, JM
    ZANI, VJ
    BUCCHERI, V
    CATOVSKY, D
    [J]. BLOOD, 1993, 82 (03) : 865 - 871
  • [9] LOCALIZATION OF AN ATAXIA-TELANGIECTASIA GENE TO CHROMOSOME 11Q22-23
    GATTI, RA
    BERKEL, I
    BODER, E
    BRAEDT, G
    CHARMLEY, P
    CONCANNON, P
    ERSOY, F
    FOROUD, T
    JASPERS, NGJ
    LANGE, K
    LATHROP, GM
    LEPPERT, M
    NAKAMURA, Y
    OCONNELL, P
    PATERSON, M
    SALSER, W
    SANAL, O
    SILVER, J
    SPARKES, RS
    SUSI, E
    WEEKS, DE
    WEI, S
    WHITE, R
    YODER, F
    [J]. NATURE, 1988, 336 (6199) : 577 - 580
  • [10] Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry
    Ginaldi, L
    Matutes, E
    Farahat, N
    DeMartinis, M
    Morilla, R
    Catovsky, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 921 - 927